Medtronic PLC vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Medtronic PLC trades at $87.9 (market cap $109.38B), while Vivmark Residential Common Shares of Beneficial Interest trades at $60.01 (market cap $45.88B). The key difference: Medtronic PLC is far larger — about 2.4× Vivmark Residential Common Shares of Beneficial Interest's market cap, and Vivmark Residential Common Shares of Beneficial Interest pays the higher dividend (4.74%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Vivmark Residential Common Shares of Beneficial Interest for 0 Days on average.
| MDT | VMRK | |
|---|---|---|
Market Cap | $109.38B | $45.88B |
Volume | 55,890,185 | 4,028,975 |
Sector | Health | Real Estate |
52-Week High | $105.35 | $70.15 |
52-Week Low | $73.75 | $57.98 |
Typical Hold Time | 63 Days | 0 Days |
Enterprise Value | $128.71B | $54.98B |
Dividend Yield | 3.37% | 4.74% |
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 0.76% on the day, with strong analyst support (60.78% buy ratings) and a $97.80 consensus price target suggesting 11.4% upside. The stock shows consistent earnings beats in recent quarters with Q3 2026 results pending, while technical indicators signal bearish momentum despite oversold RSI readings. Recent positive developments include FDA clearances for new medical technologies and a 49-year dividend growth streak with a current 3.2% yield.
MDT presents a compelling value opportunity with reasonable valuation multiples (P/E 21.06, P/S 2.93) and improving fundamentals, though technical weakness and competitive pressures warrant caution. The company's revenue growth acceleration to $33.54B in 2025 and strong cash flow generation support the dividend sustainability, while debt levels have increased to 31.11% of assets, representing a key monitoring point for investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →